New Delhi, Aug 4 (IANS) Ahead of the UN treaty on plastics, a new report in The Lancet journal on Monday has warned that plastic pollution is an underrecognised threat to the health of both humans and the planet, which must be addressed immediately.
Mumbai, Aug 4 (IANS) In a bid to increase organ donation in Maharashtra and give new life to patients awaiting transplants, the state government has launched the Organ Donation Fortnight with a range of awareness initiatives.
New Delhi, Aug 3 (IANS) In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies.
New Delhi, Aug 1 (IANS) Children under the age of five with severe malnourishment could be at significant risk of developing antimicrobial resistant bacteria, according to an alarming study.
New Delhi, Aug 2 (IANS) Scientists have found inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment.
Mumbai, Aug 1 (IANS) A letter from US President Donald Trump has asked 17 global drug giants to cut their prices in the country, sparking severe losses for them, as its impact hit the Indian stock market too.
Gandhinagar, July 31 (IANS) Gujarat is solidifying its position as a national hub for advanced lung cancer treatment, with the Gujarat Cancer and Research Institute (GCRI) in Ahmedabad treating 4,397 patients between 2020 and 2024.
New Delhi, July 31 (IANS) The Union Cabinet, chaired by Prime Minister Narendra Modi, on Thursday approved the Central Sector Scheme grant in aid to National Cooperative Development Corporation (NCDC) with an outlay of Rs 2,000 crore for a period of four years from 2025-26 to 2028-29, which works out to Rs 500 crore for each year.
New Delhi, July 31 (IANS) Researchers from the Indian Institute of Technology (IIT) Madras have developed an agriculture waste-based packaging material, which can be a sustainable alternative to conventional plastic foams used in packaging.
New Delhi, July 31 (IANS) A drug designed to treat coeliac disease -- an autoimmune disorder primarily affecting the small intestine -- has shown promise for children affected with severe post-Covid syndrome, according to a small study.
